At 15, Jonah dreaded lunchroom looks and the weight of daily injections. After a new FDA nod opened the door to inhaled insulin for younger patients, his mornings changed. What began as curiosity became relief: fewer needles, quicker dosing and fewer interruptions to his life. Families and clinicians say the …